Home » Onderzoek – Themapagina » Overzicht richtlijnen, recente literatuur

Primair hyperaldosteronisme

AdobeStock_54041095.jpg 19 augustus 2015 117 kB 560 × 169: Drawing of production cycle made by a hand
  • Arlt W.; A detour guide to the endocrine society clinical practice guideline on case detection, diagnosis and treatment of patients with primary aldosteronism; Eur J Endocrinol 2010 162: 435-438
  • Fischer E., Beuschlein F., Bidlingmaier M., Reincke M.; Commentary on the endocrine society practice guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism; Rev Endocr Metab Disord 2011 12: 43-48
  • Stowasser M., Gordon R.D.; The renaissance of primary aldosteronism: what has it taught us? Heart, Lung and Circulation 2013 22:412-420
  • Mulatero P., Monticone S., Veglio F.; Diagnosis and treatment of primary aldosteronism; Rev Endocr Metab Disord 2011 12: 3-9
  • Viola A. et al., Mulatero P.; Diagnosis and treatment of unilateral forms of primary aldosteronism; Curr Hypertension Rev 2013 9: 156-165
  • Cicala M., Mantero F.; Primary aldosteronism: what consensus for the diagnosis; Best Pract Res Clin Endocrinol Metab 2010 24: 915-921
  • Chao C. et al, Stowasser M.; Diagnosis and management of primary aldosteronism: An updated review; Ann Med 2013 45:375-383
  • Beuschlein F.; Regulation of aldosteron secretion: from physiology to disease; Eur J Endocrinol 2013 168: R85-R93
  • q Harvey A.M.; Hyperaldosteronism: Diagnosis, lateralization, treatment; Surg Clin N Am 2014 94: 643-656
  • Piaditis G., Markou A., Papanastasiou L., Androulakis I.I., Kaltsas G.; a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension; Eur J Endocrinol 2015 172: R191-R203
  • Schirpenbach C., et al, Reincke M.; The diagnosis and treatment of primary hyperaldosteronism in Germany; Dtsch Arztebl Int 2009 106(18): 305-311
  • Zennaro M., Boulkroun S., Fernandes-Rosa F.; An update on novel mechanisms of primary aldosteronism; J Endocrinol 2015 224: R63-R77
  • Fuller P.J.; Adrenal diagnostics: An endocrinologist’s perspective focused on hyperaldosteronism; Clin Biochem Rev 2013 34: 111-116
  • Layden B.T., Hahr A.J., Elaraj D.M.; Primary hyperaldosteronism: challenges in subtype classification; BMC 2012 5:602-606
  • Calhoun D.A.; Aldosteronism and hypertension; Clin J Am Soc Nephrol 2006 1: 1039- 1045
  • Ito Y., Takeda R., Takeda Y.; Subclinical primary aldosteronism; Best Prac Res Clin Endocrin Metab 2012 26: 485-495
  • Jansen P.M., van den Born B.H., Frenkel W.J., de Bruijne E.L.E., Deinum J., Kerstens M.N., Smulders Y.M., Woittiez A.J., Wijbenga J.A.M., Zietse R., Danser R.Z., van den Meiracker A.H.; Test characteristics of the aldosterone-to-renine ratio as a screening test for primary aldosteronism; J. Hypertension 2014 32: 115-126
  • Solar M., Malirova E., Ballon M., Pelouch R., Ceral J.; Confirmatory testing in primary aldosteronism: extensive medication switching is not needed in all patients; Eur J Endocrinol 2012 166: 679-686
  • Patel S.M., Lingam R.K., Beaconsfield T.I., Tran T.L., Brown B; Role of radiology in the management of primary aldosteronism; Radiographics 2007 27: 1145-1157
  • Onozawa S., Murata S., Tajima H., Yamaguchi H., Min T., Ishizaki A., Sugihara H., Oikawa S., Kumita S.; Evaluation of right adrenal vein cannulation by computed tomography angiography in 140 consecutive patients undergoing adrenal venous sampling; Eur J Endocrinol 2014 170: 601-608
  • Rossi G.P., et al Pessina A.C.; The adrenal vein sampling international study (AVIS) for identifying the major subtypes of primary aldosteronism; J Clin Endocrinol Metab 2012 97: 1606-1614
  • Rossi G.P., et al, Young W.F.; An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism; Hypertension 2014 63: 151-160
  • Salem V., et al, Tan T.; Adrenal venous sampling as a diagnostic procedure for primary hyperaldosteronism: experience from a tertiary referral centre; Hormones 2012 11(2): 151-159
  • Amar L., Lorthioir A., Azizi M., Plouin P.; Mineralocorticoid antagonist treatment for aldosterone-producing adenoma; Eur J Endocrinol 2015 172 R125-R129
  • Janmohamed S., Bouloux P.G.;The pharmacological treatment of primary aldosteronism; Expert Opin Pharmacother 2006 7(5): 563-573
  • Aronova A., Fahey III T.J., Zarnegar R.; Management of hypertension in primary aldosteronism; WJC 2014 6(5): 227-233
  • Auda S.P., Brennan M.F., Gill J.R..; Evolution of the surgical management of primary aldosteronism; Ann Surgery 1980 191(1): 1-7
  • Muth A., Ragnarsson O., Johannsson G., Wangberg B.; Systematic review of surgery and outcomes in patients with primary aldosteronism; BJS 2015 102: 307-317
  • Kline G.A., Pasieka J.L., Harvey A., So B., Dias V.C.; Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes; Ann Surg Oncol 2013 20: 2274-2278
  • Lucatello B., Benso A., Tabaro I., Capello E., Caprino M.P., Marafetti L., Rossato D., Oleandri S.E., Ghigo E., Maccario M.; Long-term re-evaluation of primary aldosteronism after medical treatment reveals high proportion of normal mineralocorticoid secretion; Eur J Endocrinol 2013 168: 525-532

bron: De nulmeting: de huidige zorg in Nederland voor mensen met een bijnieraandoening in kaart gebracht.

geplaatst: 10 oktober 2016